Q-VANT manufacturing facility is operational
November 26, 2024
Q-VANT manufacturing facility is operational
Q-VANT new state-of-the-art manufacturing facility is officially ready to start production! This cutting-edge site leverages our…
News
Q-Vant Collaborates with Tulane University to Develop a Promising New Oral Vaccine Adjuvant
February 9, 2024
Q-Vant Collaborates with Tulane University to Develop a Promising New Oral Vaccine Adjuvant
Q-Vant Biosciences Inc., a biosciences company specialized in manufacturing and formulating open-access saponin-based adjuvants from…
Q-VANT and SPI Pharma Offering Broader Access to Sustainable and Scalable Pharma-grade Saponin Adjuvants
January 31, 2024
Q-VANT and SPI Pharma Offering Broader Access to Sustainable and Scalable Pharma-grade Saponin Adjuvants
SPI Pharma, Inc. and Q-Vant Biosciences, Inc. announce a strategic partnership which includes an investment…
Q-VANT and In Vitro Plant-tech Sign Agreement for the Development and Supply of Quillaja saponaria Plant Cell Culture Biomass
March 8, 2022
Q-VANT and In Vitro Plant-tech Sign Agreement for the Development and Supply of Quillaja saponaria Plant Cell Culture Biomass
Enhances Q-VANT’s 100% sustainable supply for next-generation saponin adjuvants Boston, MA – March 8,…
QS-21 and the Quillaja Tree
January 6, 2022
QS-21 and the Quillaja Tree
The Quillaja saponaria tree is a slow-growing evergreen native to Chile whose bark has long been used…
QS-21 Supply Chain Challenges
January 6, 2022
QS-21 Supply Chain Challenges
Q-VANT Biosciences launched recently as the first company to use a computational-driven approach to solve the…
Q-VANT Biosciences Launches to Solve the Pharmaceutical Industry Problem of Limited Quillaja Saponin Adjuvants for Life-Saving Vaccines
January 6, 2022
Q-VANT Biosciences Launches to Solve the Pharmaceutical Industry Problem of Limited Quillaja Saponin Adjuvants for Life-Saving Vaccines
Company’s Innovative Technology Increases Yield of High-Quality Saponin-Based Adjuvants, Enabling the Sustainable Supply of Billions…
Q-VANT’s Chief Scientific Officer Shares Insights Gleaned from His Decades in Vaccine Development
January 6, 2022
Q-VANT’s Chief Scientific Officer Shares Insights Gleaned from His Decades in Vaccine Development
Bruce Forrest recently joined the Q-VANT team as Chief Scientific Officer, bringing more than two…
Quillaja saponaria, the Chilean Tree Under Increasing Pressure
October 6, 2021
Quillaja saponaria, the Chilean Tree Under Increasing Pressure
Quillaja saponaria Molina, commonly known as Quillay, is a tree native from Chile, used for…
